Welcome to the AVITA Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference ...

Human BioSciences, a leader in biotechnology and wound care solutions, is tackling one of our most pressing health challenges: diabetic wounds. With diabetes affecting over 500 million people ...

On February 13, 2025, amended the credit agreement with OrbiMed, adjusting the trailing 12-month revenue covenants for upcoming quarters starting from March 31, 2025, through March 31, 2026; the $115 ...

Recent research into bacterial cellulose patches may speed plants' recovery, improve grafting and help with preservation.

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...